|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.490 USD | +0.87% |
|
-5.42% | -31.97% |
| 07-06 | Alvotech Faces 'Soft' Q2 but Well Positioned to Benefit From Upcoming Biosimilar Opportunity, UBS Says | MT |
| 07-01 | Alvotech announced that it has received $175 million in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALVOTECH | Other Biotechnology & Medical Research | +0.87% | -5.42% | -31.97% | -61.31% | -64.60% | 1.25B |
-
|
-
|
-
|
- Stock Market
- Stocks
- ALVO Stock
- Charts Alvotech
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
